In recent years, Echinacea preparations have developed into the best selling herbal immunostimulants. Most of the products are derived from either the aerial or the underground parts of Echinacea purpurea, and from the roots of E. angustifolia or E. pallida. The common products in Europe mainly represent expressed juice preparations or alcoholic tinctures. The different species and preparations can be clearly distinguished phytochemically by their typical constituents. The most relevant compounds for standardization are caffeic acid derivatives (cichoric acid, echinacoside), alkamides, polyacetylenes, and glycoproteins/polysaccharides. Pharmacological studies have shown that cichoric acid, alkamides, and glycoproteins/polysaccharides possess immunomodulatory activity. Therefore they might be considered as active principles and best suited for standardization purposes. Clinical effects have been demonstrated for the expressed juice of the aerial parts of Echinacea purpurea in the adjuvant therapy of relapsing infections of the respiratory and urinary tracts, as well as for alcoholic tinctures of E. pallida and E. purpurea roots as adjuvants in the therapy of common cold and flu.
Historical Use and Botanical Aspects of Echinacea SpeciesThe genus Echinacea is endemic to North America, where it occurs in the Great Plains in between the Appalachian Mountains in the east and the Rocky Mountains in the west. Its use can be traced back to the American Indians, who regarded Echinacea as one of the most favored remedies to treat wounds, snake bites, headache and the common cold (7). The territories of the tribes that most frequently used Echinacea, show a close correspondence with the distribution range of Echinacea angustifolia. Echinacea pallida and E. purpurea, and possibly other Echinacea species have also been used, however.
140